8-A12B 1 txmd-8a12b_100617.htm REGISTRATION OF CERTAIN CLASSES OF SECURITIES
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-A


FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

TherapeuticsMD, Inc.
(Exact name of registrant as specified in its charter)

Nevada   87-0233535
(State of incorporation or organization) (I.R.S. Employer Identification No.)
     

6800 Broken Sound Parkway NW, Third Floor

Boca Raton, Florida

  33487
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered  

Name of each exchange on which

each class is to be registered

     
     
Common Stock, par value $0.001 per share   The Nasdaq Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box.  ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.  ☐

Securities Act registration statement or Regulation A offering statement file number to which this form relates: __________ (if applicable)

Securities to be registered pursuant to Section 12(g) of the Act: None

 
 

Explanatory Note

This Registration Statement on Form 8-A is being filed by TherapeuticsMD, Inc., a Nevada corporation (the “Registrant”), in connection with the registration of its common stock, par value $0.001 per share (the “Common Stock”), under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the transfer of the listing of the Common Stock to the Nasdaq Global Select Market of the Nasdaq Stock Market LLC. The Common Stock had previously been registered and listed on the NYSE American LLC under Section 12(b) of the Exchange Act.

Item 1. Description of Registrant’s Securities to be Registered.

For a description of the Common Stock to be registered see the sections entitled “Description of Common Stock” and “Certain Provisions of Nevada Law and Our Charter and Bylaws” in the Registrant’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission on November 5, 2015 and incorporated herein by reference.

Item 2. Exhibits.

Not applicable.

 
 

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

    THERAPEUTICSMD, INC.
     
     
Date: October 6, 2017   By: /s/ Daniel Cartwright
    Name: Daniel Cartwright
    Title: Chief Financial Officer